GBS Inc. to Present Third Quarter 2022 Financial Results
Company to Host Conference Call & Webcast at 4:30 p.m. ET...
Source: globenewswire.com
📰 Biosensor Platform News
Page 2 - Biosensor Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biosensor Platform. Real-time updates on events, politics, business and more.
GBS Inc. to Participate in the Upcoming March Investor
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...
Source: globenewswire.com
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
- Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing facility supported by its $4.7 Million Grant FundingAward from Australian Government -
Source: kulr8.com
IQX Limited (NSX:IQX) FDA Breakthrough Devices Designation - ABN Newswire (@ABN_Newswire)
IQX Limited (NSX:IQX) has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Device Designation.
New South Wales George Syrmalis Drug Administration Iq Group Global Life Science Biosensor Diagnostics Pty Ltd Newcastle University
Source: abnnewswire.net
FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes
/PRNewswire/ -- Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company and subsidiary of The iQ Group Global,...
New South Wales George Syrmalis James Gorman Most Innovative Companies Fd Breakthrough Devices Program Drug Administration
Source: prnewswire.com
FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes
SYDNEY, Dec. 15, 2021 /PRNewswire/ — Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company...
New South Wales George Syrmalis James Gorman Most Innovative Companies Fd Breakthrough Devices Program Drug Administration
Source: fnarena.com
GBS Inc. Announces Application for FDA Breakthrough Device
NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...
Source: globenewswire.com
GBS : Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study - Form 8-K
GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study New York, NY, November 30, 2021 - GBS Inc. , a life sciences company developing... | December 1, 2021
Source: marketscreener.com
GBS Inc. Announces Plans for C - GuruFocus.com
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Source: gurufocus.com
IQX Limited (NSX:IQX) OncoTEX Gold Compound Licensing - ABN Newswire (@ABN_Newswire)
IQX Limited (NSX:IQX) is pleased to announce that OncoTEX Inc has received licensing for a gold compound platform technology that induces the bodys immune system to destroy cancer cells.
New South Wales United States George Syrmalis Jonathanf Arambula University Of Texas At Austin Wright State University
Source: abnnewswire.net